187
Participants
Start Date
March 9, 2022
Primary Completion Date
March 3, 2025
Study Completion Date
November 15, 2025
Ifinatamab Deruxtecan (I-DXd)
I-DXd will be administered as an intravenous (IV) infusion on Day 1 of each 21-day cycle (every Q3W).
Chang Gung Memorial Hospital Linkou, Taoyuan
National Cheng Kung University Hospital Nckuh, Tainan City
Asan Medical Center, Seoul
National Taiwan University Hospital, Taipei
Memorial Sloan-Kettering Cancer Center (Mskcc) - New York, New York
National Cancer Center, Goyang-si
Montefiore Medical Center Prime, The Bronx
Taipei Veterans General Hospital, Taipei
Evangelische Lungenklinik Berlin, Berlin
Seoul National University Bundang Hospital, Seongnam-si
Hôpital Nord - Chu Marseille, Marseille
Complejo Hospitalario Universitario A Coruña, A Coruña
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Duke University Health System, Durham
Hospital Universitario Ramon Y Cajal, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Regional Universitario Malaga, Málaga
The Cancer Specialists, Llc, Jacksonville
H. Lee Moffitt Cancer Center and Research Institute, Tampa
CHU de Montpellier - Hôpital Arnaud de Villeneuve, Montpellier
Hopital Arnaud de Villeneuve, Montpellier
Sarah Cannon (Tennessee Oncology - Nashville), Nashville
Taichung Veterans General Hospital, Taichung
Hospital Virgen Macarena, Seville
Universitaetsklinikum Essen, Essen
Henry Ford Hospital, Detroit
Cancer and Hematology Centers of Western Michigan, Grand Rapids
University of Chicago Medical Center, Chicago
Washington University School of Medicine, St Louis
Centre Leon Berard, Lyon
Highlands Oncology Group, Springdale
Institut Curie - Site de Paris, Paris
Hopital Tenon, Paris
Millennium Physicians Association, Llp, Houston
Chang Gung Medical Foundation - Kaohsiung Branch, Kaohsiung City
Centre Hospitalier Intercommunal de Créteil, Créteil
University of Washington Medical Center, Seattle
Jilin Cancer Hospital, Changchun
Fudan University Shanghai Cancer Center, Shanghai
Linyi Cancer Hospital, Linyi
Zhejiang Cancer Hospital, Hangzhou
Hunan Cancer Hospital, Changsha
Union Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan
Guangdong Provincial People'S Hospital, Guangdong
West China Hospital, Sichuan University, Chengdu
Dana-Faeber Cancer Institute, Boston
Hackensack Meridian Health-Southern Ocean Medical Center, Manahawkin
National Cancer Center Hospital, Chūōku
National Cancer Center Hospital East, Kashiwa
The Cancer Institute Hospital of Jfcr, Kōtoku
Shizuoka Cancer Center, Nagaizumi-chō
Osaka International Cancer Institute, Osaka
Kindai University Hospital, Ōsaka-sayama
Kanagawa Cancer Center, Yokohama
Seoul National University Hospital, Seoul
Samsung Medical Center, Seoul
Hospital Universitario Vall Dhebron, Barcelona
Ico L'Hospitalet - Hospital Duran I Reynals, L'Hospitalet de Llobregat
Lead Sponsor
Merck Sharp & Dohme LLC
INDUSTRY
Daiichi Sankyo
INDUSTRY